Bristol Myers Squibb stock rises 5% or more within 6 months of FDA stabilization announcement
user-generated· price
Bristol Myers Squibb stock rises 5% or more within 6 months of FDA st…
Market overview
Bristol Myers Squibb CEO Chris Boerner highlighted the need for regulatory predictability, which could boost investor confidence. If the FDA commissioner nomination reduces uncertainty, the stock is likely to reflect this stability with a measurable gain.
price prediction market
- Implied probability (Yes)
- 65%
Source: user-generated
More price markets
- European space index outperforms Euro Stoxx 50 by 15% in 2026 — 60% Yes
- Oracle stock to hit $120 by Q2 2027 — 75% Yes
- NVIDIA stock rises 15% by Q4 2026 due to orbital compute demand — 68% Yes
- Nvidia stock rises above $1,500 by 2026-11-07 — 72% Yes
- Nvidia stock to exceed $1,400 by 2026-12-31 — 75% Yes
- Pharma stocks rise 10% within 6 months of stable FDA leadership — 60% Yes
- Alibaba stock recovers by 15% within 30 days — 60% Yes
- Hengrui Pharma stock gains 20% by end of 2026 — 65% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…